ArticleCancers2022
Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory
Satoshi Watanabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled ittrialcites it
ArticleCancers2022
Satoshi Watanabe et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.